CompoAtlas

Swissmed SUPA25B Capsule

Natural health product licensed in Canada

Licence holder
NuEra Nutraceutical Inc.
NPN or DIN-HM
80106127
Status
Active licence
Licence date
12 November 2020
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lactobacillus rhamnosus

Source : LR-32

2 mgNot calculated
Lactobacillus rhamnosus

Source : LR-32

400,000,000 ufcNot calculated
Lactobacillus rhamnosus

Source : Cellule entière

2 mgNot calculated
Lactobacillus rhamnosus

Source : Cellule entière

400,000,000 ufcNot calculated
Bifidobacterium animalis subsp. lactis

Source : Cellule entière

19.5 mgNot calculated
Bifidobacterium animalis subsp. lactis

Source : Cellule entière

9,750,000,000 ufcNot calculated
Bifidobacterium animalis subsp. lactis

Source : BL-04

19.5 mgNot calculated
Bifidobacterium animalis subsp. lactis

Source : BL-04

9,750,000,000 ufcNot calculated
Bifidobacterium animalis subsp. lactis

Source : R0421

2 mgNot calculated
Bifidobacterium animalis subsp. lactis

Source : R0421

200,000,000 ufcNot calculated
Bifidobacterium animalis subsp. lactis

Source : Cellule entière

2 mgNot calculated
Bifidobacterium animalis subsp. lactis

Source : Cellule entière

200,000,000 ufcNot calculated
Bifidobacterium longum subsp. longum

Source : BL-05

2 mgNot calculated
Bifidobacterium longum subsp. longum

Source : BL-05

200,000,000 ufcNot calculated
Bifidobacterium longum subsp. longum

Source : Cellule entière

2 mgNot calculated
Bifidobacterium longum subsp. longum

Source : Cellule entière

200,000,000 ufcNot calculated
Lactobacillus helveticus

Source : Cellule entière

300,000,000 ufcNot calculated
Lactobacillus helveticus

Source : Cellule entière

2 mgNot calculated
Lactobacillus helveticus

Source : Lafti L10

300,000,000 ufcNot calculated
Lactobacillus helveticus

Source : Lafti L10

2 mgNot calculated
Lactobacillus brevis

Source : Cellule entière

400,000,000 ufcNot calculated
Lactobacillus brevis

Source : Cellule entière

2 mgNot calculated
Lactobacillus brevis

Source : Lbr-35

400,000,000 ufcNot calculated
Lactobacillus brevis

Source : Lbr-35

2 mgNot calculated
Inuline

Source : Cichorium intybus - racine

240 mgNot calculated
Inuline

Source : Inuline

240 mgNot calculated
Lacticaseibacillus paracasei

Source : Cellule entière

800,000,000 ufcNot calculated
Lacticaseibacillus paracasei

Source : Cellule entière

2 mgNot calculated
Lacticaseibacillus paracasei

Source : LPC-37

800,000,000 ufcNot calculated
Lacticaseibacillus paracasei

Source : LPC-37

2 mgNot calculated

Non-medicinal ingredients

Chlorure de sodium, Gomme arabique (acacia), Sucrose, Hydroxypropyl méthylcellulose, Stéarate de magnésium, Cellulose microcristalline, Phosphate de dipotassium, Phosphate de potassium monobasique, Ascorbate de sodium, Trehalose, Dioxyde de titane, Phosphate de tricalcium, Eau purifiée

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Source of probiotics.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80106127

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line